1. 304am永利集团

    Reliable Quality

    Affordable Innovation

    Name Indication Clinical Trial Phase Study Title
    HLX01
    RA
    Phase I/II

    A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

    HLX01
    RA
    Phase III

    A Phase III Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis